Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).

Date Range:

	Sage Therapeutics	Eidos Therapeutics	Biohaven Pharmaceutical	Maravai LifeSciences	Atea Pharmaceuticals
Symbol	NASDAQ:SAGE	NASDAQ:EIDX	NYSE:BHVN	NASDAQ:MRVI	NASDAQ:AVIR
Price Information
Current Price	$70.43	$122.21	$77.87	$34.00	$62.89
52 Week Range	Hold	Hold	Buy	Buy	Buy
MarketRank™
Overall Score	1.4	1.0	1.8	1.9	1.7
Analysis Score	3.2	1.0	3.4	2.5	1.5
Community Score	3.1	2.3	2.4	5.0	5.0
Dividend Score	0.0	0.0	0.0	0.0	0.0
Ownership Score	0.0	1.7	2.5	0.0	0.0
Earnings & Valuation Score	0.6	0.0	0.6	1.9	1.9
Analyst Ratings
Consensus Recommendation	Hold	Hold	Buy	Buy	Buy
Consensus Price Target	$80.50	$53.45	$95.30	$37.13	$58.33
% Upside from Price Target	14.30% upside	-56.26% downside	22.38% upside	9.19% upside	-7.25% downside
Trade Information
Market Cap	$4.45 billion	$4.75 billion	$4.75 billion	$6.13 billion	$5.83 billion
Beta	2.23	-0.16	1.09	N/A	N/A
Average Volume	501,336	128,113	588,131	1,204,767	271,859
Sales & Book Value
Annual Revenue	$6.87 million	$26.69 million	N/A	N/A	N/A
Price / Sales	598.52	177.99	N/A	N/A	N/A
Cashflow	N/A	N/A	N/A	N/A	N/A
Price / Cash	N/A	N/A	N/A	N/A	N/A
Book Value	$18.23 per share	$4.57 per share	($0.14) per share	N/A	N/A
Price / Book	3.86	26.74	N/A	N/A	N/A
Profitability
Net Income	$-680,240,000.00	$-37,830,000.00	$-528,800,000.00	N/A	N/A
EPS	($13.38)	($1.03)	($10.91)	N/A	N/A
Trailing P/E Ratio	N/A	N/A	N/A	0.00	0.00
Forward P/E Ratio	N/A	N/A	N/A	57.63	17.82
P/E Growth	N/A	N/A	N/A	N/A	N/A
Net Margins	-7,706.84%	N/A	N/A	N/A	N/A
Return on Equity (ROE)	-63.81%	-65.21%	-1,091.41%	N/A	N/A
Return on Assets (ROA)	-56.64%	-53.04%	-120.85%	N/A	N/A
Dividend
Annual Payout	N/A	N/A	N/A	N/A	N/A
Dividend Yield	N/A	N/A	N/A	N/A	N/A
Three-Year Dividend Growth	N/A	N/A	N/A	N/A	N/A
Payout Ratio	N/A	N/A	N/A	N/A	N/A
Years of Consecutive Dividend Growth	N/A	N/A	N/A	N/A	N/A
Debt
Debt-to-Equity Ratio	N/A	0.14%	N/A	N/A	N/A
Current Ratio	11.71%	11.10%	3.26%	N/A	N/A
Quick Ratio	11.71%	11.10%	3.17%	N/A	N/A
Ownership Information
Institutional Ownership Percentage	N/A	31.40%	99.37%	N/A	N/A
Insider Ownership Percentage	4.80%	70.10%	19.10%	N/A	N/A
Miscellaneous
Employees	675	70	647	N/A	11
Shares Outstanding	58.38 million	38.87 million	59.94 million	168.66 million	82.62 million
Next Earnings Date	5/6/2021 (Estimated)	N/A	5/6/2021 (Estimated)	6/1/2021 (Estimated)	3/11/2021 (Estimated)
Optionable	Optionable	Not Optionable	Optionable	Not Optionable	Not Optionable

Comparison Ideas:

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Your Ultimate Investing Toolkit

Just $1.00 for your first month.

Compare Stocks

30 Days of MarketBeat All Access for $1.00

Premium Research Tools

Market Data and Calendars

Investing Education and Resources